Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-1,245,000
Closed -$70.7M 11
2025
Q1
$70.7M Sell
1,245,000
-310,000
-20% -$20.2M 5.56% 9
2024
Q4
$105M Hold
1,555,000
7.01% 7
2024
Q3
$104M Hold
1,555,000
5.95% 7
2024
Q2
$107M Buy
1,555,000
+430,000
+38% +$28.5M 5.16% 6
2024
Q1
$68.9M Hold
1,125,000
3.49% 7
2023
Q4
$70.1M Hold
1,125,000
3.34% 7
2023
Q3
$55.1M Buy
+1,125,000
New +$57.5M 2.77% 9
2023
Q1
Sell
-2,731,227
Closed -$115M 13
2022
Q4
$115M Buy
2,731,227
+460,000
+20% +$17.6M 4.32% 7
2022
Q3
$72M Hold
2,271,227
3.51% 8
2022
Q2
$80.8M Sell
2,271,227
-51,000
-2% -$1.96M 3.24% 9
2022
Q1
$94.7M Buy
+2,322,227
New +$99.4M 3.02% 8

Other funds holding SKX

Theleme Partners's SKX Position: Q2 2025 in Review

Theleme Partners sold out of Skechers (SKX) in Q2 2025, closing a stake of 1,245,000 shares — an estimated $70.7M sold.

Theleme Partners first reported a position in SKX in Q1 2022 and held it in 11 quarters. The position peaked at $115M in Q4 2022. 465 funds tracked by Wall St. Rank hold SKX as of Q2 2025.

  • Theleme Partners reported no remaining Skechers position as of Q2 2025 after selling out during the quarter.
  • Theleme Partners sold 1,245,000 Skechers shares in Q2 2025, an estimated $70.7M.
  • Theleme Partners first reported a position in Skechers in Q1 2022 and held it in 11 quarters.
  • Theleme Partners's Skechers position peaked at $115M in Q4 2022.
  • 465 funds tracked by Wall St. Rank held Skechers as of Q2 2025.

Based on Theleme Partners's 13F filing for Q2 2025, filed 14 Aug 2025.